- Home
- INAB vs PAVM Comparison
INAB vs PAVM Comparison
Compare INAB & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INAB
- PAVM
- Stock Information
- Founded
- INAB 2016
- PAVM 2014
- Country
- INAB United States
- PAVM United States
- Employees
- INAB N/A
- PAVM N/A
- Industry
- INAB Biotechnology: Pharmaceutical Preparations
- PAVM Medical/Dental Instruments
- Sector
- INAB Health Care
- PAVM Health Care
- Exchange
- INAB Nasdaq
- PAVM Nasdaq
- Market Cap
- INAB 10.6M
- PAVM 9.4M
- IPO Year
- INAB 2021
- PAVM 2016
- Fundamental
- Price
- INAB $1.63
- PAVM $0.38
- Analyst Decision
- INAB Strong Buy
- PAVM Strong Buy
- Analyst Count
- INAB 2
- PAVM 1
- Target Price
- INAB $108.00
- PAVM $20.00
- AVG Volume (30 Days)
- INAB 72.9K
- PAVM 772.9K
- Earning Date
- INAB 11-06-2025
- PAVM 11-13-2025
- Dividend Yield
- INAB N/A
- PAVM N/A
- EPS Growth
- INAB N/A
- PAVM N/A
- EPS
- INAB N/A
- PAVM N/A
- Revenue
- INAB N/A
- PAVM $29,000.00
- Revenue This Year
- INAB N/A
- PAVM N/A
- Revenue Next Year
- INAB N/A
- PAVM $234.47
- P/E Ratio
- INAB N/A
- PAVM N/A
- Revenue Growth
- INAB N/A
- PAVM N/A
- 52 Week Low
- INAB $1.53
- PAVM $0.30
- 52 Week High
- INAB $12.53
- PAVM $1.25
- Technical
- Relative Strength Index (RSI)
- INAB 32.35
- PAVM 48.79
- Support Level
- INAB $1.53
- PAVM $0.32
- Resistance Level
- INAB $1.77
- PAVM $0.41
- Average True Range (ATR)
- INAB 0.17
- PAVM 0.04
- MACD
- INAB -0.02
- PAVM -0.00
- Stochastic Oscillator
- INAB 12.28
- PAVM 56.14
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.